Reagentes e instrumentos para imunologia, biologia celular e biologia molecular.
 
> Primary Ovarian Cancer Maintenance Media (Ince OCMI-L) (Liquid)

Primary Ovarian Cancer Maintenance Media (Ince OCMI-L) (Liquid)

Imprimir Imprimir
Please log in

Referência 506390-500ml

Tamanho : 500ml

Marca : US Biological

Contactar o distribuidor local :


Telefone : +1 850 650 7790

506390 Primary Ovarian Cancer Maintenance Media (Ince OCMI-L) (Liquid)

Shipping Temp
Blue Ice
Storage Temp
4°C Do Not Freeze/-20°C

Primary Ovarian Cancer Maintenance Media (Ince).

Use OCMI-L medium for established OCI lines only.

Suggested Usage:
PRIMARY HUMAN OVARIAN CARICINOMA CELL LINES
OCI-C1p Clear Cell Primary
OCI-C4p Clear Cell Primary
OCI-C5x Clear Cell Xenograft
OCI-P2a Serous Ascites
OCI-P5x Serous Xenograft
OCI-P7a Serous Ascites
OCI-P8p Serous Primary
OCI-P9a1 Serous Ascites
FCI-P2p Serous Primary
OCI-CSp Carcinosacroma

Tan A. Ince, MD, PhD - Fighting Cancer by Keeping Cancer Cells Alive ...
https://www.scientia.global/tan-ince-md-phd-fighting-cancer-keeping-cancer-cells-alive/

Feb 12, 2017 - Professor Ince was a visiting clinical scientist at the Massachusetts Institute of Technology from 2000 to 2007, where he developed a new cell culture nutrient medium that is now widely used to grow human breast and ovary cells.

Customer supplied:
To be supplemented with 5% fetal bovine serum to media
To be supplemented with Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media.

Appearance:
Red, clear, complete

OCMI-L Bullet 1 Included (506390B, Colorless):
Supplied as a liquid. Thaw, vortex, spin down and add whole vial to 506390.

Storage (506390B):
Liquid is stable at 4°C.

OCMI-L Bullet 2 Included (506390C, Pink):
Supplied as a liquid. Thaw, vortex, spin down and add whole vial to 506390.

Storage (506390C):
Liquid is stable at -20°C.

Storage and Stability
(w/o supplements):
Store at 4°C. Do not freeze. Stable for 6 months w/o supplements. Light sensitive, store in the dark.

Storage and Stability
(w/ supplements):
Complete media with supplements is stable for 6 weeks at 4°C. Do Not Freeze.
Light sensitive, store in the dark.

Country of Origin:
United States

Important Note:
Cholera toxin is NOT included in the liquid media nor the bullet. Shipping regulations have made it increasingly difficult to ship. Please procure from your local supplier. Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media.

Licensed by TumorGenesisTM. Manufactured for research use by US Biological.

Applications
Important Note: |This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. ||Toxicity and Hazards: |All products should be handled by qualified personnel only, trained in laboratory procedures.
References
1. Tan A. Ince, MD, PhD - Fighting Cancer by Keeping Cancer Cells Alive ...https://www.scientia.global/tan-ince-md-phd-fighting-cancer-keeping-cancer-cells-alive. 2. AE Witt, CW Lee, TI Lee, DI Azzam, B Wang, C Caslini, F Petrocca, J Grosso, M Jones, EB Cohick, AB Gropper, C Wahlestedt, AL Richardson, R Shiekhattar, RA Young and TA Ince, Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer, Oncogene, 2016. DOI: 10.1038/ onc.2016.337. 3. A Thakkar, B Wang, M Picon-Ruiz, P Buchwald and TA Ince, Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer, Breast Cancer Res. Treat., 2016, 157, 77–90. 4. TA Ince, AD Sousa, MA Jones, JC Harrell, ES Agoston, M Krohn, LM Selfors, W Liu, K Chen, M Yong, P Buchwald, B Wang, KS Hale, E Cohick, P Sergent, A Witt, Z Kozhekbaeva, S Gao, AT Agoston, MA Merritt, R Foster, BR Rueda, CP Crum, JS Brugge, GB Mills, Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours, Nat. Commun., 2015, 6, 7419. 5. S Santagata, A Thakkar, A Ergonul, B Wang, T Woo, R Hu, JC Harrell, G McNamara, M Schwede, AC Culhane, D Kindelberger, S Rodig, A Richardson, SJ Schnitt, RM Tamimi and TA Ince, Taxonomy of breast cancer based on normal cell phenotype predicts outcome, J. Clin. Invest., 2014, 124, 859–870.